Eﬃcacy and safety of short course chemotherapy regimens in older children and adolescents with multiple and extensive drug resistant respiratory tuberculosis

Eﬃcacy and safety of short course chemotherapy regimens in older children and adolescents with multiple and extensive drug resistant respiratory tuberculosis

The objective of the study: to evaluate the eﬃcacy and safety of short course chemotherapy regimens for multiple/extensive drug resistant tuberculosis of the respiratory system (MDR/XDR) in older children and adolescents.Subjects and Methods. A cohort prospective controlled study (2017 to 2019) incl...

Full description

Bibliographic Details
Main Authors:	L. V. Panova, E. S. Ovsyankina, E. A. Krushinskaya, A. Yu. Khiteva, O. A. Piskunova
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2021-11-01
Series:	Туберкулез и болезни лёгких
Subjects:	tuberculosis mdr/xdr mbt children adolescents short course chemotherapy regimens bedaquiline
Online Access:	https://www.tibl-journal.com/jour/article/view/1578

Similar Items

Short-Course Chemotherapy Regimens for Treatment of Multiple and Pre-Extensive Drug Resistant Tuberculosis in Combination with Surgery in Older Children and Adolescents
by: E. S. Ovsyankina, et al.
Published: (2024-12-01)

Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance
by: N. Yu. Nikolenko, et al.
Published: (2023-07-01)

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

Justification of Chemotherapy Duration in Patients with Multiple and Pre-Extensive Drug Resistant Tuberculosis in the Russian Federation
by: A. I. Gayda, et al.
Published: (2023-01-01)

A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT
by: Jingtao Gao, et al.
Published: (2024-04-01)

Immediate and Postponed Results of Short-Course Chemotherapy Regimens Containing Bedaquiline in Tuberculosis Patients with Multiple Drug Resistance
by: P. N. Golubchikov, et al.
Published: (2023-08-01)

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
by: Andrey Maryandyshev, et al.
Published: (2017-10-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Short course chemotherapy in children suffering from drug resistant tuberculosis
by: N. I. Klevno, et al.
Published: (2021-03-01)

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
by: Jay Achar, et al.
Published: (2017-10-01)

Monitoring the Cardiotoxic Effects of Bedaquiline in Older Children and Adolescents with Multiple and Extensive Drug Resistance
by: O. A. Piskunova, et al.
Published: (2023-12-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
by: A. О. Mаryandyshev, et al.
Published: (2019-08-01)

Classifying new anti-tuberculosis drugs: rationale and future perspectives
by: Simon Tiberi, et al.
Published: (2017-03-01)

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
by: Yousra Kherabi, et al.
Published: (2022-09-01)

atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure
by: Laure Fournier Le Ray, et al.
Published: (2022-05-01)

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
by: Zarir F. Udwadia, et al.
Published: (2019-01-01)

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
by: Giovanni Sotgiu, et al.
Published: (2017-03-01)

Delamanid in the Treatment of MDR/pre-XDR TB in Arkhangelsk Region in 2019–2021
by: E. S. Khimova, et al.
Published: (2023-07-01)

Non-Injection Chemotherapy Regimens for Drug Resistant Tuberculosis in Children and Adolescents
by: V. A. Aksenova, et al.
Published: (2023-12-01)

Epidemiology of multidrug-resistant, extensively drug resistant, and totally drug resistant tuberculosis in Middle East countries
by: Mohanad M Ahmed, et al.
Published: (2016-01-01)

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan
by: Shona Horter, et al.
Published: (2020-09-01)

High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates
by: Kanwara Trisakul, et al.
Published: (2022-12-01)

Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives
by: A. E. Russkikh, et al.
Published: (2021-01-01)

Real World Experience of Bedaquiline-Based Anti-Tubercular Regime in Multi-Drug Resistant Tuberculosis.
by: Vikas Marwah, et al.
Published: (2025-01-01)

Trends in tuberculosis clinicians’ adoption of short-course regimens for latent tuberculosis infection
by: Pei-Jean I. Feng, et al.
Published: (2023-12-01)

Simulation of Conditions and Results of Implementation of Short-Course Treatment Regimes in Tuberculosis Patients
by: V. S. Burykhin, et al.
Published: (2023-12-01)

Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps
by: Hasan Ghajavand, et al.
Published: (2019-05-01)

New regimens and new medications in the treatment of tuberculosis: keeping step?
by: Ruzanov D.Y., et al.
Published: (2021-04-01)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
by: Uzma Khan, et al.
Published: (2019-08-01)

Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-12-01)

Safety of chemotherapy of MDR/XDR-TB patients in high HIV prevalence settings
by: A. V. Kukurika, et al.
Published: (2022-12-01)

Increased Notification of Tuberculosis Cases and MDR and XDR Cases Post Introduction of CBNAAT in Rajasthan: A Retrospective Case Study of 4 Years from 2015-2018
by: Neil Sharma1 , Manish Kumar Singhal2 , Rachna Agrawal3 , Manoj Sharma4 , Sona Goyal5
Published: (2021-10-01)

Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China
by: Yan Hu, et al.
Published: (2023-02-01)

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
by: Mohammad Javad Nasiri, et al.
Published: (2022-11-01)

Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam
by: Thi Mai Phuong Nguyen, et al.
Published: (2023-01-01)

Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
by: Roshni Mary Prince, et al.
Published: (2023-08-01)

Effectiveness and safety of regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis
by: Oki Nugraha Putra, et al.
Published: (2024-04-01)

Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis
by: Oki Nugraha Putra, et al.
Published: (2023-01-01)